BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11302413)

  • 1. Pneumococcal resistance: the treatment challenge.
    Amsden GW; Amankwa K
    Ann Pharmacother; 2001 Apr; 35(4):480-8. PubMed ID: 11302413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates.
    Pérez-Trallero E; Marimon JM; Iglesias L; Larruskain J
    Emerg Infect Dis; 2003 Sep; 9(9):1159-62. PubMed ID: 14519256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.
    Dowell SF; Butler JC; Giebink GS; Jacobs MR; Jernigan D; Musher DM; Rakowsky A; Schwartz B
    Pediatr Infect Dis J; 1999 Jan; 18(1):1-9. PubMed ID: 9951971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
    Chen DK; McGeer A; de Azavedo JC; Low DE
    N Engl J Med; 1999 Jul; 341(4):233-9. PubMed ID: 10413735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of drug-resistant pneumococcal infections in the United States.
    Breiman RF; Butler JC; Tenover FC; Elliott JA; Facklam RR
    JAMA; 1994 Jun; 271(23):1831-5. PubMed ID: 8196139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.
    Cornick JE; Bentley SD
    Microbes Infect; 2012 Jul; 14(7-8):573-83. PubMed ID: 22342898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.
    Doern GV
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S187-92. PubMed ID: 11524718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms].
    Sidorenko SV
    Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumococcal antibiotic resistance].
    Moreillon P; Wenger A; Caldelari I
    Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolones and pneumococci.
    Tillotson GS; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):709-10. PubMed ID: 10797099
    [No Abstract]   [Full Text] [Related]  

  • 15. Pneumococcal drug resistance: the new "special enemy of old age".
    Butler JC; Cetron MS
    Clin Infect Dis; 1999 Apr; 28(4):730-5. PubMed ID: 10825028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia.
    Mayanskiy N; Alyabieva N; Ponomarenko O; Lazareva A; Katosova L; Ivanenko A; Kulichenko T; Namazova-Baranova L; Baranov A
    Int J Infect Dis; 2014 Mar; 20():58-62. PubMed ID: 24462930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptococcus pneumoniae and beta-lactam antibiotic agents].
    Ranin L; Vucković-Opavski N; Berger-Jekić O
    Srp Arh Celok Lek; 1996; 124(1-2):18-23. PubMed ID: 9102809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in pneumococcal antibiotic resistance.
    Song JH
    Expert Rev Respir Med; 2013 Oct; 7(5):491-8. PubMed ID: 24138693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.